04.01.2014 Views

Broker-Dealer Litigation - Greenberg Traurig LLP

Broker-Dealer Litigation - Greenberg Traurig LLP

Broker-Dealer Litigation - Greenberg Traurig LLP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

to judgment as a matter of law because the evidence at trial failed to establish that the defendant<br />

made false or misleading statements to the public with the requisite scienter and that he was a<br />

control person with respect to plaintiffs’ claim under Section 20(a). The court found that<br />

sufficient evidence was presented at trial to support the jury’s finding regarding defendant’s<br />

control person liability under Section 20(a). Specifically, the court found that the plaintiffs<br />

presented testimony at trial regarding defendant’s power to direct or cause the direction of<br />

management, as well as his power to direct or cause the direction of the policies of persons that<br />

prepared the relevant financial statements at issue. Thus, the court denied defendant’s motion for<br />

judgment as a matter of law.<br />

In re Toyota Motor Corp. Securities <strong>Litigation</strong>, 2011 WL 2675395 (C.D. Cal. July 7, 2011).<br />

Plaintiff shareholders brought suit against a corporation and its officers for material<br />

misrepresentations regarding the quality and safety of its products in violation of Section 10(b)<br />

and Section 20(a) of the Securities Exchange Act of 1934. Defendants moved to dismiss. After<br />

finding that there were violations of Section 10(b), the court found that the complaint failed to<br />

plead facts that sufficiently established that the individual defendants had actual control or power<br />

over the individuals who made the misrepresentations. As such, the Section 20(a) claims were<br />

dismissed.<br />

Stichting Pensioenfonds ABP v. Countrywide Fin. Corp., 80 F. Supp.2d 1125 (C.D. Cal. 2011).<br />

Plaintiff sued a corporation, its affiliates, and certain individuals based on Sections 11,<br />

12(a)(2), and 15 of the Securities Act of 1933, and Sections 10(b) and 20(a) of the Securities<br />

Exchange Act of 1934. Defendants moved to dismiss on multiple grounds. The court found that<br />

because Section 13 of the Securities Act provides a one-year statute of limitations and a threeyear<br />

statute of repose on claims under Sections 11 and 12(a)(2), and because the statute of repose<br />

had run, the claims under Sections 11 and 12(a)(2) must be dismissed. Further, because a claim<br />

under Section 15 for control person liability requires an adequately pled claim under Sections 11<br />

or 12(a)(2), it was dismissed as well. The court found that the Section 10(b) claims were also<br />

precluded either by the statute of repose or the statute of limitations, and because Section 20(a)<br />

control person liability requires a predicate violation, those claims were dismissed as well.<br />

Nguyen v. Radient Pharms. Corp., 2011 U.S. Dist. LEXIS 124631 (C.D. Cal. Oct. 26, 2011).<br />

Plaintiffs brought a federal securities class action against a pharmaceutical corporation<br />

and its officers on behalf of all persons and entities who purchased the common stock of<br />

defendant during a particular time period. Plaintiffs argued that defendants issued a materially<br />

false and misleading press release stating that the corporation had combined with a prestigious<br />

medical organization to conduct a clinical trial together. Plaintiffs alleged that the individual<br />

defendants acted as “control persons” of the corporation within the meaning of Section 20(a) of<br />

the Securities Exchange Act of 1934. Plaintiffs alleged that the individual defendants:<br />

H.2<br />

H.2<br />

H.2<br />

257

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!